يعرض 8,741 - 8,760 نتائج من 18,405 نتيجة بحث عن 'significantly ((((teer decrease) OR (((we decrease) OR (a decrease))))) OR (observed decrease))', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 8741

    Evaluation index system of EEC and RPH. حسب Qian Xie (43047)

    منشور في 2024
    "…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …"
  2. 8742

    The framework of this paper. حسب Qian Xie (43047)

    منشور في 2024
    "…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …"
  3. 8743

    Global Moran’s I for CCD (Selected Years). حسب Qian Xie (43047)

    منشور في 2024
    "…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …"
  4. 8744

    Spatial MTPM for the CCD of EEC and RPH. حسب Qian Xie (43047)

    منشور في 2024
    "…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …"
  5. 8745

    Influencing factors of CCD. حسب Qian Xie (43047)

    منشور في 2024
    "…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …"
  6. 8746

    Kernel density estimation of the CCD. حسب Qian Xie (43047)

    منشور في 2024
    "…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …"
  7. 8747

    National and regional results of CCD. حسب Qian Xie (43047)

    منشور في 2024
    "…KDE results indicate a rightward shift in the density curve of the CCD, suggesting a significant reduction in absolute disparities. …"
  8. 8748

    Data Sheet 1_Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis.pdf حسب Peipei Li (552532)

    منشور في 2025
    "…There was no significant difference in the risk of AF/AFL between the high-dose SGLT2 inhibitors group and the low-dose SGLT2 inhibitors group (RR 0.78; 95%CI, 0.60–1.02; I<sup>2</sup> = 0%; P = 0.07), although a decreasing trend in the high-dose group was noted. …"
  9. 8749

    Analysis of differential microbiome and classification prediction model between case and control groups. حسب Chuan Zhang (187157)

    منشور في 2025
    "…<p><b>(A)</b> Linear discriminant analysis [LDA; (log10)>2] and (B) effect size (LEfSe) analysis revealed significant differences (P < 0.01) in the microbiota of the case (orange, negative score) and control groups (blue, positive score) groups. …"
  10. 8750

    Surgical changes through ISIW implantation. حسب Sayaka Kimura-Uchida (22793666)

    منشور في 2025
    "…Pre- and postoperative data are compared by Tukey’s HSD test and asterisks mean statistical significance (p < 0.05). IOP decreases significantly from 3 to 12 months after surgery whereas GMS decreases from one day to 12 months after surgery. …"
  11. 8751

    The <i>ENT2</i> knockout effects on CRC proliferation and survival. حسب Safaa M. Naes (22075434)

    منشور في 2025
    "…Plating Efficiency (PE) was calculated as the ratio of the number of colonies to the number of cells seeded. PE decreased significantly in both HKO1 and HKO2. No significant difference occurred between NTC and DKO cells. …"
  12. 8752

    Search strategy. حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"
  13. 8753

    Fig 1 - حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"
  14. 8754

    GMT by age cohort for PWH and PWoH. حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"
  15. 8755

    Fig 4 - حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"
  16. 8756

    Difference in GMT for HPV16 and HPV18 in PWH. حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"
  17. 8757

    Fig 3 - حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"
  18. 8758

    Summary of characteristics of studies reviewed. حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"
  19. 8759

    Cumulative meta-analysis. حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"
  20. 8760

    Summary of immunogenicity information. حسب Alvine M. Akumbom (20460907)

    منشور في 2024
    "…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …"